# BONVIVA(Ibandronate) PMS(Post-marketing Surveillance )

> **NCT01381393** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 659 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** Ibandronate

## Key facts

- **NCT ID:** NCT01381393
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 659 (ACTUAL)
- **Last updated:** 2012-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01381393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01381393, "BONVIVA(Ibandronate) PMS(Post-marketing Surveillance )". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01381393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*